Relative Strength Chart Repligen Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
171 ^USD	-2.84%		+3.72%	-4.88%

May. 14	Transcript : Repligen Corporation Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 10:30 AM
May. 02	UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating	MT

End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	REPLIGEN CORPORATION	Other Medical Equipment, Supplies & Distribution	-2.84%	+3.72%	-4.88%	+12.63%	+144.50%	9.56B